These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-001574-27 Sevoflurane on cardiac surgery: vantage to use during CEC not-yet-due
Ongoing 2006-006210-14 PIPERACILLIN/TAZOBACTAM PLUS TIGECYCLINE VS. PIPERACILLIN/TAZOBACTAM ALONE AS EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIC CANCER PATIENTS : A PROSPECTIVE, RANDOMISED, MULTI-CENTRE, STUDY. not-yet-due
Completed, but no date 2007-006773-92 Sodium Valproate in the treatment of medication overuse headache: a controlled randomized clinical trial. bad-data
Ongoing 2008-002077-12 Ā“Fenoldopam end Renal failureĀ” (FENO-HSR) not-yet-due
Ongoing 2008-008382-35 Open , multicenter, randomized trial comparing two therapeutic approaches for the treatment of invasive fungal infections in neutropenic onco-hematologic patients.Empiric vs. ``presumptive`` (preempt... not-yet-due
Ongoing 2009-017437-22 MANAGEMENT OF PRIMARY AND SECUNDARY PERITONEAL CARCINOMATOSIS FROM COLO-RECTAL CANCER, RECURRENT OVARIAN CANCER AND ABDOMINAL SARCOMATOSIS BY CYTOREDUCTIVE SURGERY PLUS HYPERTHERMIC INTRAPERITONEAL CH... not-yet-due
Ongoing 2009-017603-28 Aprepitant for prevention of acute and delayed nausea and vomiting: a phase III, double-blind, randomized, palcebo-controlled trial in patients receiving a high-emetogenic dose of cyclophosphamide for... not-yet-due
Ongoing 2011-002992-40 PREvention of VENous Thromboembolism In Hemorrhagic Stroke patients not-yet-due
Ongoing 2011-005487-13 A phase II, multi-center, open label study of the clinical activity and safety of the BRAF-V600 inhibitor vemurafenib (PLX-4032) in previously treated patients with hairy cell leukemia (HCL) carrying... not-yet-due
Ongoing 2014-000693-18 A PHASE II STUDY OF THE CLINICAL ACTIVITY AND SAFETY OF ACTINOMYCIN D IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA WITH NUCLEOPHOSMIN (NPM1) GENE MUTATION not-yet-due
Ongoing 2020-001475-33 Treatment with COLchicine of patients affected by COVID-19: a Pilot Study not-yet-due